Kestra Medical Technologies, Ltd.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -190.8% | -148.7% | -136.9% | -122.5% | -119.3% | -137.5% | -135.6% | -81.3% | -74.8% | -65.4% | -104.3% | -82.2% | |
| – | 40.6% | 34.8% | 18.6% | 12.7% | 12.5% | 10.7% | 10.5% | 10.5% | 8.1% | 8.1% | 8.6% | 8.8% | |
| – | 4.5% | 3.9% | 2.9% | 7.6% | 3.0% | 129.5% | 23.6% | 38.3% | 41.2% | 36.0% | 30.7% | 36.2% | |
| – | 17.8% | 26.9% | -11.3% | -9.7% | -2.4% | -20.1% | -30.9% | 3.2% | 8.6% | 17.2% | -24.2% | 0.2% | |
| – | 60.0% | 41.8% | 55.2% | 30.1% | 29.8% | 46.7% | 42.2% | 32.2% | 39.9% | 33.7% | 26.9% | 32.9% | |
| – | -60.0% | -41.4% | -55.0% | -30.3% | -29.5% | -45.0% | -42.5% | -32.9% | -60.8% | -603.1% | -68.9% | -202.8% | |
| – | 1.3% | 2.6% | 8.0% | 3.9% | 0.3% | 0.0% | 0.0% | 0.0% | 0.1% | 1.0% | 0.6% | 0.5% | |
| – | – | – | – | – | 0.0% | 0.0% | 0.0% | – | – | – | 92.4% | – | |
| – | 143.7% | 121.7% | 909.5% | -3.9% | -0.8% | 1,245.9% | -9.7% | -0.1% | 607.6% | -0.6% | 72.6% | 160.7% | |
| – | -107.1% | -68.3% | 717.6% | -156.7% | -149.5% | 1,063.3% | -187.8% | -114.3% | 472.0% | -669.1% | -100.6% | -124.3% | |
| – | -250.9% | -190.5% | -192.1% | -152.6% | -148.8% | -184.2% | -177.8% | -113.5% | -114.7% | -99.1% | -131.2% | -115.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.